Literature DB >> 26646397

Highly specific detection of Cryptosporidium spp. oocysts in human stool samples by undemanding and inexpensive phase contrast microscopy.

Ralf Ignatius1,2, Thomas Klemm3, Steffen Zander4,5, Jean Bosco Gahutu6, Peter Kimmig3, Frank P Mockenhaupt4, Thomas Regnath3.   

Abstract

To compare phase contrast microscopy (PCM) of unstained slides for the detection of Cryptosporidium spp. oocysts with a commercially available enzyme immunoassay (EIA) for the detection of cryptosporidial antigen in human stool samples, we prospectively analysed by both methods 463 fresh human stool samples obtained from diarrhoeic patients between July and October 2014. Compared with the EIA, the sensitivity, specificity, positive and negative predictive value of PCM were 88.9 % (95 % confidence interval (CI), 66.0-98.1 %), 100 % (95 % CI, 99.0-100 %), 100 % (95 % CI, 77.3-100 %) and 99.6 % (95 % CI, 98.3-100 %), respectively. Additionally, we retrospectively examined with PCM 65 fixed stool samples that had been collected in 2010 from mostly asymptomatic Rwandan children <5 years of age; 14 of these samples had previously yielded positive results with a highly sensitive real-time (RT)-PCR. PCM detected cryptosporidia in 5/14 RT-PCR-positive samples, and notably, also in one of 51 RT-PCR-negative samples, which was subsequently confirmed by acid-fast staining. Positive and negative percent agreement of PCM with RT-PCR were 35.7 % (95 % CI, 16.2-61.4 %) and 98.0 % (95 % CI, 88.7-100 %), respectively. Positive PCM results were associated with higher RT-PCR cycle threshold values (p = 0.044). In conclusion, PCM offers a highly specific, undemanding and inexpensive method for the laboratory diagnosis of acute human cryptosporidiosis independent of the causative Cryptosporidium species.

Entities:  

Keywords:  Cryptosporidium; ELISA; Phase contrast microscopy; RT-PCR; Rwandan children

Mesh:

Substances:

Year:  2015        PMID: 26646397     DOI: 10.1007/s00436-015-4859-3

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  40 in total

1.  Incidence of cryptosporidiosis species in paediatric patients in Malawi.

Authors:  T D Morse; R A B Nichols; A M Grimason; B M Campbell; K C Tembo; H V Smith
Journal:  Epidemiol Infect       Date:  2007-01-15       Impact factor: 2.451

2.  Identification of a high diversity of Cryptosporidium species genotypes and subtypes in a pediatric population in Nigeria.

Authors:  Síle F Molloy; Huw V Smith; Patrick Kirwan; Rosely A B Nichols; Samuel O Asaolu; Lisa Connelly; Celia V Holland
Journal:  Am J Trop Med Hyg       Date:  2010-04       Impact factor: 2.345

3.  [A simple technic for the demonstration of cryptosporidia in feces].

Authors:  J Heine
Journal:  Zentralbl Veterinarmed B       Date:  1982-05

4.  Threshold of detection of Cryptosporidium oocysts in human stool specimens: evidence for low sensitivity of current diagnostic methods.

Authors:  R Weber; R T Bryan; H S Bishop; S P Wahlquist; J J Sullivan; D D Juranek
Journal:  J Clin Microbiol       Date:  1991-07       Impact factor: 5.948

5.  Evaluation of three commercial assays for detection of Giardia and Cryptosporidium organisms in fecal specimens.

Authors:  Stephanie P Johnston; Melissa M Ballard; Michael J Beach; Louise Causer; Patricia P Wilkins
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

6.  Cryptosporidium sp. in stool specimens from diarrhoeic and asymptomatic individuals in the Magdeburg area (East Germany).

Authors:  W Schuster; R Fischer; S Alsleben; B Schuster
Journal:  Angew Parasitol       Date:  1991-11

7.  Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study.

Authors:  Karen L Kotloff; James P Nataro; William C Blackwelder; Dilruba Nasrin; Tamer H Farag; Sandra Panchalingam; Yukun Wu; Samba O Sow; Dipika Sur; Robert F Breiman; Abu Sg Faruque; Anita Km Zaidi; Debasish Saha; Pedro L Alonso; Boubou Tamboura; Doh Sanogo; Uma Onwuchekwa; Byomkesh Manna; Thandavarayan Ramamurthy; Suman Kanungo; John B Ochieng; Richard Omore; Joseph O Oundo; Anowar Hossain; Sumon K Das; Shahnawaz Ahmed; Shahida Qureshi; Farheen Quadri; Richard A Adegbola; Martin Antonio; M Jahangir Hossain; Adebayo Akinsola; Inacio Mandomando; Tacilta Nhampossa; Sozinho Acácio; Kousick Biswas; Ciara E O'Reilly; Eric D Mintz; Lynette Y Berkeley; Khitam Muhsen; Halvor Sommerfelt; Roy M Robins-Browne; Myron M Levine
Journal:  Lancet       Date:  2013-05-14       Impact factor: 79.321

Review 8.  Cryptosporidiosis in children in Sub-Saharan Africa: a lingering challenge.

Authors:  Siobhan M Mor; Saul Tzipori
Journal:  Clin Infect Dis       Date:  2008-10-01       Impact factor: 9.079

9.  High prevalence of Giardia duodenalis Assemblage B infection and association with underweight in Rwandan children.

Authors:  Ralf Ignatius; Jean Bosco Gahutu; Christian Klotz; Christian Steininger; Cyprien Shyirambere; Michel Lyng; Andre Musemakweri; Toni Aebischer; Peter Martus; Gundel Harms; Frank P Mockenhaupt
Journal:  PLoS Negl Trop Dis       Date:  2012-06-12

10.  Cryptosporidium spp., Giardia duodenalis, Enterocytozoon bieneusi and other intestinal parasites in young children in Lobata province, Democratic Republic of São Tomé and Principe.

Authors:  Maria Luísa Lobo; João Augusto; Francisco Antunes; José Ceita; Lihua Xiao; Vera Codices; Olga Matos
Journal:  PLoS One       Date:  2014-05-20       Impact factor: 3.240

View more
  2 in total

Review 1.  An overview of methods/techniques for the detection of Cryptosporidium in food samples.

Authors:  Shahira A Ahmed; Panagiotis Karanis
Journal:  Parasitol Res       Date:  2018-01-19       Impact factor: 2.289

2.  Molecular characterization of Giardia intestinalis and Cryptosporidium parvum from calves with diarrhoea in Austria and evaluation of point-of-care tests.

Authors:  Katharina Lichtmannsperger; Barbara Hinney; Anja Joachim; Thomas Wittek
Journal:  Comp Immunol Microbiol Infect Dis       Date:  2019-07-12       Impact factor: 2.268

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.